TY  - JOUR
AU  - Novillo Villajos, Apolonia
AU  - Gaibar, María
AU  - Romero Lorca, Alicia
AU  - Gilsanz, María Fuencisla
AU  - Beltrán, Laura
AU  - Galán, Miguel
AU  - Antón, Beatriz
AU  - Malón, Diego
AU  - Moreno, Amalia
AU  - Fernández Santander, Ana
PY  - 2020
DO  - 10.3748/wjg.v26.i16.1979
SN  - 1007-9327
UR  - https://hdl.handle.net/20.500.14352/130301
T2  - World Journal of Gastroenterology
AB  - Background: In metastatic colorectal cancer (mCRC), the anti-vascular endothelial growth factor drug bevacizumab (BVZ) plus chemotherapy significantly improves progression-free survival compared to chemotherapy (CT) alone. This benefit is not,...
LA  - eng
M2  - 1979
PB  - Baishideng Publishing Group
KW  - Bevacizumab
KW  - Case report
KW  - Chemokine CXCL5
KW  - Colorectal cancer
KW  - Gene expression
KW  - Progression-free survival
TI  - Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
TY  - journal article
VL  - 26
ER  -